日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/04/26 | 4,271 | 4,348 | 4,240 | 4,335 | +28 | +0.7% | 176,200 |
| 2024/04/25 | 4,320 | 4,351 | 4,300 | 4,307 | +11 | +0.3% | 170,400 |
| 2024/04/24 | 4,327 | 4,343 | 4,296 | 4,296 | +1 | ±0% | 209,600 |
| 2024/04/23 | 4,288 | 4,330 | 4,269 | 4,295 | +7 | +0.2% | 159,000 |
| 2024/04/22 | 4,257 | 4,295 | 4,235 | 4,288 | +83 | +2% | 225,000 |
| 2024/04/19 | 4,240 | 4,249 | 4,182 | 4,205 | -39 | -0.9% | 230,400 |
| 2024/04/18 | 4,275 | 4,301 | 4,243 | 4,244 | -41 | -1% | 234,500 |
| 2024/04/17 | 4,335 | 4,339 | 4,272 | 4,285 | -51 | -1.2% | 209,000 |
| 2024/04/16 | 4,263 | 4,340 | 4,240 | 4,336 | +56 | +1.3% | 225,900 |
| 2024/04/15 | 4,300 | 4,311 | 4,263 | 4,280 | -59 | -1.4% | 170,700 |
| 2024/04/12 | 4,247 | 4,341 | 4,245 | 4,339 | +84 | +2% | 278,100 |
| 2024/04/11 | 4,326 | 4,326 | 4,247 | 4,255 | -79 | -1.8% | 413,100 |
| 2024/04/10 | 4,322 | 4,372 | 4,321 | 4,334 | -2 | ±0% | 136,700 |
| 2024/04/09 | 4,341 | 4,363 | 4,297 | 4,336 | -26 | -0.6% | 221,800 |
| 2024/04/08 | 4,375 | 4,378 | 4,339 | 4,362 | -10 | -0.2% | 167,700 |
| 2024/04/05 | 4,311 | 4,372 | 4,300 | 4,372 | +40 | +0.9% | 306,800 |
| 2024/04/04 | 4,333 | 4,348 | 4,302 | 4,332 | +14 | +0.3% | 247,900 |
| 2024/04/03 | 4,301 | 4,353 | 4,267 | 4,318 | +3 | +0.1% | 354,600 |
| 2024/04/02 | 4,397 | 4,402 | 4,287 | 4,315 | -102 | -2.3% | 465,200 |
| 2024/04/01 | 4,480 | 4,484 | 4,415 | 4,417 | -53 | -1.2% | 260,200 |
| 2024/03/29 | 4,480 | 4,490 | 4,455 | 4,470 | -17 | -0.4% | 267,400 |
| 2024/03/28 | 4,589 | 4,598 | 4,445 | 4,487 | -137 | -3% | 396,300 |
| 2024/03/27 | 4,599 | 4,625 | 4,574 | 4,624 | +51 | +1.1% | 333,800 |
| 2024/03/26 | 4,560 | 4,580 | 4,514 | 4,573 | +6 | +0.1% | 204,000 |
| 2024/03/25 | 4,662 | 4,677 | 4,567 | 4,567 | -89 | -1.9% | 246,800 |
| 2024/03/22 | 4,660 | 4,684 | 4,615 | 4,656 | -15 | -0.3% | 295,800 |
| 2024/03/21 | 4,650 | 4,685 | 4,620 | 4,671 | +56 | +1.2% | 357,300 |
| 2024/03/19 | 4,580 | 4,615 | 4,563 | 4,615 | -6 | -0.1% | 367,100 |
| 2024/03/18 | 4,524 | 4,625 | 4,513 | 4,621 | +100 | +2.2% | 321,100 |
| 2024/03/15 | 4,501 | 4,536 | 4,481 | 4,521 | +1 | ±0% | 269,100 |
| 2024/03/14 | 4,492 | 4,520 | 4,438 | 4,520 | +28 | +0.6% | 266,300 |
| 2024/03/13 | 4,514 | 4,541 | 4,464 | 4,492 | -51 | -1.1% | 300,400 |
| 2024/03/12 | 4,579 | 4,580 | 4,444 | 4,543 | -13 | -0.3% | 303,900 |
| 2024/03/11 | 4,533 | 4,581 | 4,482 | 4,556 | +36 | +0.8% | 418,300 |
| 2024/03/08 | 4,424 | 4,525 | 4,350 | 4,520 | +26 | +0.6% | 548,500 |
| 2024/03/07 | 4,560 | 4,605 | 4,451 | 4,494 | -72 | -1.6% | 590,700 |
| 2024/03/06 | 4,431 | 4,584 | 4,414 | 4,566 | +54 | +1.2% | 638,700 |
| 2024/03/05 | 4,645 | 4,652 | 4,484 | 4,512 | -273 | -5.7% | 954,500 |
| 2024/03/04 | 4,801 | 4,847 | 4,779 | 4,785 | -5 | -0.1% | 401,000 |
| 2024/03/01 | 4,805 | 4,940 | 4,790 | 4,790 | +20 | +0.4% | 415,500 |
| 2024/02/29 | 4,790 | 4,804 | 4,716 | 4,770 | -22 | -0.5% | 509,300 |
| 2024/02/28 | 4,794 | 4,897 | 4,781 | 4,792 | -72 | -1.5% | 571,300 |
| 2024/02/27 | 4,807 | 4,877 | 4,800 | 4,864 | +46 | +1% | 506,000 |
| 2024/02/26 | 4,860 | 4,900 | 4,801 | 4,818 | -22 | -0.5% | 922,700 |
| 2024/02/22 | 4,931 | 4,961 | 4,840 | 4,840 | -91 | -1.8% | 544,600 |
| 2024/02/21 | 4,941 | 4,955 | 4,896 | 4,931 | -19 | -0.4% | 195,200 |
| 2024/02/20 | 4,972 | 4,982 | 4,945 | 4,950 | -12 | -0.2% | 231,300 |
| 2024/02/19 | 5,049 | 5,050 | 4,946 | 4,962 | -87 | -1.7% | 251,400 |
| 2024/02/16 | 4,938 | 5,049 | 4,891 | 5,049 | +161 | +3.3% | 284,700 |
| 2024/02/15 | 4,912 | 4,922 | 4,827 | 4,888 | -44 | -0.9% | 345,900 |
1～
50
件表示中 / 3445件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 433,500円 | +2.0% | +11.5% | 2.86% | 11.23倍 | 1.38倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 参天薬 | 151,200円 | +8.2% | - | 2.18% | 18.61倍 | 1.79倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| 久光薬 | 377,900円 | +7.3% | -3.8% | 2.38% | 18.12倍 | 1.08倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ツムラ | 375,500円 | +8.5% | -4.5% | 1.86% | 17.60倍 | 1.08倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サワイＧＨＤ | 595,700円 | -10.2% | +17.3% | 2.18% | 23.09倍 | 1.22倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
市場注目の銘柄
チャート関連のコラム
